About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of T-PRED(TM) Compared to Pred Forte(R) II | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00854061

Study of T-PRED(TM) Compared to Pred Forte(R) II

Study of T-PRED(TM) Compared to Pred Forte(R)

Lead sponsor: Bausch & Lomb Incorporated•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Bausch & Lomb Incorporated

This study was a multi-center, randomized, double-masked, bioequivalence study. A total of 172 participants undergoing bilateral cataract surgery were assigned investigational product to each eye according to a computer-generated randomization list for each of 2 study variables: treatment with T-PRED or Pred Forte in the first eye undergoing cataract extraction and the aqueous humor sampling time point. The investigator determined which eye was clinically suited for the first operative procedure; treatment of this eye was randomized to either T-PRED or Pred Forte. The second eye received the other study treatment (RP if the first eye received T-PRED; T-PRED if the first eye received Pred Forte) at the time of the second cataract extraction.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 years of age or older

Exclusion Criteria

•No active or adverse disease

Related studies

Stress Ball Use During Cataract Surgery: Effects on Pain, Fear and Satisfaction

NCT07452770 · Pain, Fear, and more

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

NCT06979752 · Glaucoma, Open Angle, Pseudo-exfoliative, Cataract

Assessment of a Hand-held Femtosecond Laser to Perform Anterior Capsulorhexis During Cataract Surgery (Post-market Study)

NCT07362043 · Cataract Surgery

IC-8 Apthera IOL New Enrollment Post Approval Study

NCT06060041 · Cataract, Presbyopia, and more

HUD Surgical Guidance for Toric Alignment

NCT07325188 · Cataract and IOL Surgery

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 20, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment172

Start dateFeb 2009

Last updatedOct 20, 2020

Condition

Locations shown

ISTA Pharmaceuticals, Inc.

Irvine, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2020Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions